The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | An ongoing study investigating stereotypy in CLL and characterizing major stereotyped subsets
Andreas Agathangelidis, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses an ongoing study assessing the phenomenon of stereotypy in chronic lymphocytic leukemia (CLL). The initiative aims not only to determine the frequency of stereotypy in CLL but also to identify and characterize major stereotyped subsets. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
